New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
PHARMACEUTICAL ECONSULTING A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S (CVR number: 30815378) is a company from ALBERTSLUND. The company recorded a gross profit of 6113.7 kDKK in 2025. The operating profit was -1268.2 kDKK, while net earnings were -1067 kDKK. The profitability of the company measured by Return on Assets (ROA) was -11.6 %, which can be considered poor and Return on Equity (ROE) was -18.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 48.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. PHARMACEUTICAL ECONSULTING A/S's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | |||||
| Gross profit | 8 276.39 | 6 778.72 | 5 578.65 | 5 454.29 | 6 113.71 |
| EBIT | 3 050.41 | 770.09 | - 394.89 | - 941.30 | -1 268.24 |
| Net earnings | 2 419.81 | 779.62 | - 383.63 | - 643.85 | -1 066.96 |
| Shareholders equity total | 6 467.43 | 7 247.05 | 6 863.42 | 6 219.57 | 5 152.61 |
| Balance sheet total (assets) | 19 657.84 | 8 092.29 | 7 990.63 | 8 806.14 | 10 595.15 |
| Net debt | 6 989.45 | -59.53 | - 351.35 | 1 189.09 | 3 437.44 |
| Profitability | |||||
| EBIT-% | |||||
| ROA | 18.2 % | 9.0 % | -3.3 % | -9.7 % | -11.6 % |
| ROE | 46.0 % | 11.4 % | -5.4 % | -9.8 % | -18.8 % |
| ROI | 22.3 % | 10.6 % | -3.8 % | -11.0 % | -12.9 % |
| Economic value added (EVA) | 1 682.08 | - 222.02 | - 863.50 | -1 024.93 | -1 485.58 |
| Solvency | |||||
| Equity ratio | 32.9 % | 89.6 % | 85.9 % | 70.6 % | 48.6 % |
| Gearing | 151.7 % | 0.2 % | 27.4 % | 84.9 % | |
| Relative net indebtedness % | |||||
| Liquidity | |||||
| Quick ratio | 1.5 | 9.4 | 7.0 | 3.3 | 1.9 |
| Current ratio | 1.5 | 9.4 | 7.0 | 3.3 | 1.9 |
| Cash and cash equivalents | 2 824.62 | 59.53 | 363.13 | 515.48 | 935.15 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | |||||
| Net working capital % | |||||
| Credit risk | |||||
| Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.